The nation of Zimbabwe has declined a major US health deal worth 367 million US dollars (£272m) over five years due to the United States' request for confidential data.
The decision became public after a official document dated December was leaked, indicating that President Emmerson Mnangagwa believed the agreement was "skewed".
A government spokesperson has since stated that the US was requesting health data for scientific study and profit while was unwilling to guarantee the resulting advantages from future medical innovations.
"We will now turn to the challenging and unfortunate process of ending our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had donated more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged further talks to find a agreement suitable to both sides so the country's vital HIV programme can be sustained.
Broader Background
This development comes after a comparable situation in neighbouring Kenya, where a high court halted a similar deal with the US following concerns were filed about the safety of citizens' health data.
After returning to office last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
The agency had administered aid for the US government, but Trump argued its spending was "wasteful" and his administration was seeking direct bilateral deals to enhance transparency and responsibility.
According to statements, 16 nations in Africa have so far signed these new agreements, constituting more than $18.3bn in committed funds.
Details of the Rejected Agreement
The money for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment through US-supported programmes," Tremont said.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, without any corresponding guarantee of benefiting from any medical innovations – like new medicines or tests – that could be developed from that shared data," he stated.
"In essence, our nation would provide the raw materials for scientific discovery without any assurance that the final treatments would be available to our population should a future pandemic arise."
Sovereignty and Global Health
He also said that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were upending systems already established through the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing framework designed to deal with potential global health emergencies.
"This framework is designed to guarantee that when a nation provides its information, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to create them."
These objections regarding the US deal "are not meant as hostility towards the US," he added.
"We encourage continued discussions with our American counterparts on how subsequent collaboration could be structured in a manner that honours the independence and interests of each country."
Health Experts Response
Medical experts expressed it acknowledged the government's concerns, but urged that talks must proceed given that much of the country's Aids initiatives depended on external financing.
"In cases where specific concerns exist, including those involving information security or implementation frameworks, these can frequently be addressed via detailed discussion and mutually agreed protections," it said.
The situation highlights the ongoing challenges between receiving much-needed international aid and protecting a country's data in an ever more interconnected world.